Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001654954-26-002112·Giordano Christopher Thomas
Schedule 13D ownership disclosure
Tenax Therapeutics, Inc.
Common Stock, $0.0001 par value per share · CUSIP: 88032L605
Event date: 2025-12-10
- Filing-level shares
- 1,252,965
- Percent of class
- 6.79%
- Christopher Thomas GiordanoReported CIK 0001871714
Shares: 1,252,965 · Class: 6.79%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001654954-26-002112
- Form type
- SCHEDULE 13D
- Filer
- Giordano Christopher Thomas
- CIK
- CIK 1871714
- Filed
- Mar 10, 2026
- Reporting period
- Dec 10, 2025
- Description
- Schedule 13D beneficial ownership